Abbott Er-Eia Monoclonal Diag. Kit
by Abbott Laboratories PMA
Withdrawn
PMA P850029
Overview
This device is a Kit, Assay, Estrogen Receptor (OpenFDA classification), designed for the qualitative detection of estrogen receptors in human breast tissue. It employs a monoclonal antibody-based enzyme immunoassay (EIA) to measure estrogen receptor presence, aiding in the assessment of hormone receptor status for breast cancer diagnosis and treatment planning.
The Abbott ER-EIA Monoclonal Diagnostic Kit is intended for use in clinical chemistry laboratories under sterile conditions. Supplied as a single-use diagnostic kit, it requires proper storage at controlled temperatures and adherence to manufacturer instructions for specimen collection and slide preparation. Authorized under FDA_PMA (PMA number P850029), it complies with regulatory requirements for device class 3 (regulation number 864.1860) and is distributed under product code LPJ. Minor labeling updates have been approved to mitigate interference risks from dyes like methylene blue.
Regulatory status
Withdrawn since 17 Oct 1988. The authorization below is no longer in force.
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPWD | NumberP850029 | Date17 Oct 1988 | StatusWithdrawn |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA PMA Withdrawn
Specification
- Generic Name
- KIT, ASSAY, ESTROGEN RECEPTOR
- PMA Number
- FDA Product Code
- LPJ
- Regulation
- 21 CFR Part 864.1860
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- APWD Approval withdrawn